Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY

by Hal Lindon, Benzinga Editor
March 9, 2022 6:03 AM | 3 seconds read |
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Click to see more Earnings updates
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved